- Report
- December 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- April 2024
- 101 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Cinepazide is a cardiovascular drug used to treat hypertension and angina pectoris. It is a calcium channel blocker, which works by blocking the influx of calcium ions into the cells of the heart and blood vessels, thus reducing the force of contraction of the heart and dilating the blood vessels. Cinepazide is available in both oral and intravenous forms, and is often used in combination with other drugs to treat hypertension.
Cinepazide is widely used in the treatment of cardiovascular diseases, and is one of the most commonly prescribed drugs in this field. It is generally well tolerated, with few side effects, and is considered to be a safe and effective treatment for hypertension and angina pectoris.
The cinepazide market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Novartis, Sanofi, Merck, and GlaxoSmithKline. Show Less Read more